These findings provide valuable insights into the evolving landscape of obesity management in this population
Published Research and References for Semaglutide Lau J, Bloch P, Schffer L, et al
Precautions References In a randomized, single-blind, placebo-controlled trial including 150 obese participants, individuals received either 16g per day of native inulin or maltodextrin (placebo) along with dietary advice focused on consuming either inulin-rich or inulin-poor vegetables
A standard U-100 insulin syringe has 100 units per 1mL
They assessed participants clinical parameters, dietary intake, and eating behaviors at the start of the study, 3 months after the start, and 12 months after the start